• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
GID
Click for more information
0.00% 0.2¢

GI DYNAMICS, INC

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
GID
Ann: GID Announces US $1M Convertible Note & Warrant Financing 		18/03/19 0 160
18/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  160 
GID
Ann: UK NHS EndoBarrier Service Releases Final One-Year Data 		15/03/19 0 219
15/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  219 
GID
Ann: Appendix 4G - Annual Report 		13/03/19 0 90
13/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  90 
GID
Ann: Appendix 4E - Preliminary Final Report 		28/02/19 0 92
28/02/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  92 
GID
Ann: GID Announces IRB Approval for EndoBarrier Pivotal Trial 		14/02/19 0 120
14/02/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  120 
GID
Ann: Appendix 4C - quarterly 		31/01/19 0 133
31/01/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  133 
GID
Ann: GID Appoints VP of Clinical and Regulatory Affairs 		04/01/19 0 169
04/01/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  169 
GID
Ann: Extension of the Maturity Date of US $5M Convertible Note 		02/01/19 0 264
02/01/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  264 

See All Discussions arrow Created with Sketch.

Top Stories

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Cyclone signs MOU with Vale for development of Iron Bear play Cyclone Metals Lt has signed a Memorandum of Understanding with Vale S.A to support development of the former's iron ore project in Canada
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch CuFe Ltd (ASX:CUF) has decided not to wait around for Northern Star's Crossroads mine to get up and running, selling its $4M royalty right.
Banshee's historic trenches prove rich in antimony and gold for GDM Great Divide Mining Ltd has found high-grade antimony and gold through geochemical sampling at its Banshee prospect in Queensland
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.